Peptide TherapeuticsPeer Reviewed
A randomised controlled trial confirms the non-superiority of bone marrow aspirate (BMA) from the posterior iliac crest and proximal tibia compared to platelet rich plasma (PRP) in the treatment of knee osteoarthritis.
Authors (9)
Elisabetta MormoneInstitute for Stem Cell Biology, Regenerative Medicine and Innovative Therapies (ISBReMIT) Fondazione IRCCS "Casa Sollievo della Sofferenza" San Giovanni Rotondo Foggia Italy.
Leonardo SavastanoDepartment of Orthopedics and Trauma Surgery Fondazione IRCCS "Casa Sollievo della Sofferenza" San Giovanni Rotondo Foggia Italy.
Valeria GuerraInstitute for Stem Cell Biology, Regenerative Medicine and Innovative Therapies (ISBReMIT) Fondazione IRCCS "Casa Sollievo della Sofferenza" San Giovanni Rotondo Foggia Italy.
Marco SandriBig and Open Data Innovation Laboratory (BODaI-Lab) University of Brescia Brescia Italy.
Journal of experimental orthopaedics
Unknown
Published
Oct 13, 2025
Abstract
Abstract not available - data parsing issue resolved
Keywords
BMAMSCsMarrow Cellution™ Aspiration SystemPRPknee osteoarthritis (KOA)
Article Metrics
Sourcepubmed
Related Research
Explore more articles in this research category to discover related studies and findings.